Nanoparticles modulate surfactant protein A and D mediated protection against influenza A infection in vitro

• Published in: Philosophical transactions of the Royal Society of London. Series B. Biological sciences Vol. 370; no. 1661; p. 20140049
• Main Authors: McKenzie, Zofi, Kendall, Michaela, Mackay, Rose-Marie, Tetley, Teresa D., Morgan, Cliff, Griffiths, Mark, Clark, Howard W., Madsen, Jens
• Format: Journal Article
• Language: English
• Published: England The Royal Society 05.02.2015
• Subjects: Cell Line, Tumor; Collectin; Humans; Influenza A virus - physiology; Innate Immunity; Mucosal; Nanoparticles; Pulmonary Surfactant-Associated Protein A - genetics; Pulmonary Surfactant-Associated Protein A - metabolism; Pulmonary Surfactant-Associated Protein D - metabolism; Surface Chemistry; Surfactant; nanoparticles; surface chemistry; innate immunity; collectin; surfactant; mucosal
• ISSN: 0962-8436; 1471-2970
• DOI: 10.1098/rstb.2014.0049

Numerous epidemiological and toxicological studies have indicated that respiratory infections are exacerbated following enhanced exposure to airborne particulates. Surfactant protein A (SP-A) and SP-D form an important part of the innate immune response in the lung and can interact with nanoparticles to modulate the cellular uptake of these particles. We hypothesize that this interaction will also affect the ability of these proteins to combat infections. TT1, A549 and differentiated THP-1 cells, representing the predominant cell types found in the alveolus namely alveolar type I (ATI) epithelial cells, ATII cells and macrophages, were used to examine the effect of two model nanoparticles, 100 nm amine modified (A-PS) and unmodified polystyrene (U-PS), on the ability of SP-A and SP-D to neutralize influenza A infections in vitro. Pre-incubation of low concentrations of U-PS with SP-A resulted in a reduction of SP-A anti-influenza activity in A549 cells, whereas at higher concentrations there was an increase in SP-A antiviral activity. This differential pattern of U-PS concentration on surfactant protein mediated protection against IAV was also shown with SP-D in TT1 cells. On the other hand, low concentrations of A-PS particles resulted in a reduction of SP-A activity in TT1 cells and a reduction in SP-D activity in A549 cells. These results indicate that nanoparticles can modulate the ability of SP-A and SP-D to combat viral challenges. Furthermore, the nanoparticle concentration, surface chemistry and cell type under investigation are important factors in determining the extent of these modulations.